Longevity Science Foundation and Aging Research at King's are running a joint event to highlight the potential of psychedelic applications for mental health and longevity.

Mental health matters for human longevity. It directly influences brain health and physical well-being. Researchers believe better and more accessible approaches to mental health treatments, including new applications of psychedelics like psilocybin and cannabis, will unlock breakthrough understanding of other ageing-related diseases like Alzheimer’s disease and Parkinson’s disease. Big things are happening in the space, and the Longevity Science Foundation and King’s College London have partnered to bring these discoveries to us all.

Speakers include Professors Allan Young, Dag Aarsland, Dr Guy Goodwin and Lisa Ireland.